RxDoctor Payments Data

Jenny Cyphers, NP

Acute Care · Galax, VANPI 1902507353

Payments from drug & device makers

$1,443in general payments, 2019–2025

Across 68 payments — averaging $21.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$309
  • AstraZeneca$219
  • Novartis$164
  • Abbott$132
  • Johnson & Johnson$122
  • Boehringer Ingelheim$114
  • plus $382 from 6 others

What the payments were for

  • Food & beverage$1,443100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,443 in reported general payments places this provider in the 75th percentile of 599 acute care providers in Virginia.

See all acute care providers in Virginia

Medicare billing

Part B allowed, 2024
$50,500
Medicare patients
430
Services billed
902

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban173$177,597
EntrestoSacubitril/Valsartan130$125,961
XareltoRivaroxaban58$65,924
FarxigaDapagliflozin Propanediol76$54,592
BrilintaTicagrelor20$16,080
JardianceEmpagliflozin14$12,124
VascepaIcosapent Ethyl26$8,098
Dabigatran EtexilateDabigatran Etexilate Mesylate17$4,545
Metoprolol Succinate193$1,480
Nitroglycerin56$904
Metoprolol Tartrate172$780
Losartan Potassium82$779
Hydrochlorothiazide150$766
Ranolazine ErRanolazine17$727
Diltiazem 24hr Er (Cd)Diltiazem Hcl19$721

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$19$177,597173 claims
NovartisEntresto$164$125,961130 claims
AstraZenecaFarxiga, Brilinta$219$70,67296 claims
Johnson & JohnsonXarelto$122$65,92458 claims
Boehringer IngelheimJardiance$114$12,12414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 599 acute care providers in Virginia.

Other acute care in Galax

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →